| 2012 | Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometry | ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY |
| 2011 | DNA methylation predicts recurrence from resected stage III proximal colon cancer
| CANCER |
| 2011 | MMP-2 as a putative biomarker for carcinomatosis in gastric cancer | HEPATO-GASTROENTEROLOGY |
| 2011 | A densely interconnected genome-wide network of microRNAs and oncogenic pathways revealed using gene expression signatures
| PLOS GENETICS |
| 2011 | Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2011 | Phase II study of sunitinib as second-line treatment for advanced gastric cancer
| INVESTIGATIONAL NEW DRUGS |
| 2011 | Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
| CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2011 | Treatment of recurrent hepatocellular carcinoma after liver transplantation | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2011 | Inflammatory and tumor stimulating responses after laparoscopic sigmoidectomy
| YONSEI MEDICAL JOURNAL |
| 2011 | CD44-SLC1A2 gene fusions in gastric cancer.
| SCIENCE TRANSLATIONAL MEDICINE |
| 2011 | Biweekly gemcitabine-paclitaxel, gemcitabine-carboplatin, or gemcitabine-cisplatin as first-line treatment in metastatic breast cancer after anthracycline failure: a phase II randomized selection trial. | BREAST CANCER |
| 2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | ONCOLOGY |
| 2011 | A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis | ONCOLOGY |
| 2011 | Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer | ANTI-CANCER DRUGS |
| 2011 | A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy
| CANCER |
| 2011 | Prevalence and associated factors of psychological distress among Korean cancer patients | GENERAL HOSPITAL PSYCHIATRY |
| 2011 | Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen. | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2011 | Genome-wide molecular characterization of mucinous colorectal adenocarcinoma using cDNA microarray analysis. | ONCOLOGY REPORTS |
| 2011 | Identification of genes associated with chemosensitivity to SAHA/taxane combination treatment in taxane-resistant breast cancer cells | BREAST CANCER RESEARCH AND TREATMENT |
| 2010 | Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites
| CANCER RESEARCH AND TREATMENT |
| 2010 | The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up | ANNALS OF SURGICAL ONCOLOGY |
| 2010 | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. | LANCET |
| 2010 | Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma | INTERNATIONAL JOURNAL OF HYPERTHERMIA |
| 2010 | Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2010 | Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine? | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2010 | Identification of novel gastric cancer-associated CNVs by integrated analysis of microarray | JOURNAL OF SURGICAL ONCOLOGY |
| 2010 | Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression | CANCER SCIENCE |
| 2010 | A phase I pharmacokinetic and pharmacodynamic study of CKD-732, an antiangiogenic agent, in patients with refractory solid cancer | INVESTIGATIONAL NEW DRUGS |
| 2010 | Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2010 | Analysis of overall survival from a phase III study of ixabepilone plus capecitabine versus capecitabine in patients with MBC resistant to anthracyclines and taxanes | BREAST CANCER RESEARCH AND TREATMENT |
| 2010 | A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
| 2010 | A phase I/II and pharmacogenomic study of pemetrexed and cisplatin in patients with unresectable, advanced gastric carcinoma. | ANTI-CANCER DRUGS |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2010 | The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2010 | Identification of genes related to a synergistic effect of taxane and suberoylanilide hydroxamic acid combination treatment in gastric cancer cells | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2010 | A phase II study of a combined biweekly irinotecan and monthly cisplatin treatment for metastatic or recurrent gastric cancer. | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
| 2010 | Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. | ONCOLOGY REPORTS |
| 2010 | Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
| 2010 | Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients | CANCER LETTERS |
| 2009 | Benefits of recurrent colonic stent insertion in a patient with advanced gastric cancer with carcinomatosis causing colonic obstruction
| YONSEI MEDICAL JOURNAL |
| 2009 | Activity of ixabepilone in oestrogen receptor-negative and oestrogen receptor-progesterone receptor-human epidermal growth factor receptor 2-negative metastatic breast cancer | EUROPEAN JOURNAL OF CANCER |
| 2009 | Changes of telomerase activity by alternative splicing of full-length and beta variants of hTERT in breast cancer patients. | ONCOLOGY RESEARCH |
| 2009 | Docetaxel versus paclitaxel combined with 5-FU and leucovorin in advanced gastric cancer: combined analysis of two phase II trials.
| CANCER RESEARCH AND TREATMENT |
| 2009 | A phase II feasibility study of weekly paclitaxel in heavily pretreated advanced gastric cancer patients with poor performance status | ONCOLOGY |
| 2009 | Increments of alpha-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer | JOURNAL OF SURGICAL ONCOLOGY |
| 2009 | Standardized genetic alteration score and predicted score for predicting recurrence status of gastric cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2009 | Prognosis of pN3 stage gastric cancer
| CANCER RESEARCH AND TREATMENT |
| 2009 | Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea
| CANCER RESEARCH AND TREATMENT |
| 2009 | Oncogenic pathway combinations predict clinical prognosis in gastric cancer
| PLOS GENETICS |
| 2009 | Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening
| YONSEI MEDICAL JOURNAL |
http://orcid.org/0000-0002-0920-9471
(7404006815)
